0.4746
price up icon13.41%   +0.0561
after-market  After Hours:  .4535  -0.0211   -4.45%
loading
Fresh2 Group Ltd ADR stock is currently priced at $0.4746, with a 24-hour trading volume of 46,284. It has seen a +13.41% increased in the last 24 hours and a +35.56% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $0.4198 pivot point. If it approaches the $0.4627 resistance level, significant changes may occur.
Previous Close:
$0.4185
Open:
$0.4396
24h Volume:
46,284
Market Cap:
$11.64M
Revenue:
$1.77M
Net Income/Loss:
$-15.05M
P/E Ratio:
-0.0593
EPS:
-7.9989
Net Cash Flow:
$-21.35M
1W Performance:
+12.31%
1M Performance:
+35.56%
6M Performance:
-54.85%
1Y Performance:
+0.00%
1D Range:
Value
$0.4101
$0.4773
52W Range:
Value
$0.2999
$2.60

Fresh2 Group Ltd ADR Stock (FRES) Company Profile

Name
Name
Fresh2 Group Ltd ADR
Name
Phone
-
Name
Address
650 5th Ave, Suite 2416, New York
Name
Employee
75
Name
Twitter
Name
Next Earnings Date
2024-06-11
Name
Latest SEC Filings
Name
FRES's Discussions on Twitter

Fresh2 Group Ltd ADR Stock (FRES) Financials Data

Fresh2 Group Ltd ADR (FRES) Revenue 2024

FRES reported a revenue (TTM) of $1.77 million for the quarter ending December 31, 2022, a -36.58% decline year-over-year.
loading

Fresh2 Group Ltd ADR (FRES) Net Income 2024

FRES net income (TTM) was -$15.04 million for the quarter ending December 31, 2022, a +18.18% increase year-over-year.
loading

Fresh2 Group Ltd ADR (FRES) Cash Flow 2024

FRES recorded a free cash flow (TTM) of -$21.35 million for the quarter ending June 30, 2022.
loading

Fresh2 Group Ltd ADR (FRES) Earnings per Share 2024

FRES earnings per share (TTM) was -$7.9989 for the quarter ending December 31, 2022, a +70.39% growth year-over-year.
loading
Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.
$77.56
price up icon 0.77%
$149.40
price down icon 1.20%
$29.98
price up icon 1.11%
$172.85
price up icon 1.06%
$365.81
price down icon 2.87%
$90.61
price down icon 2.55%
Cap:     |  Volume (24h):